- Ownership hops held
- 55
An absent edge means not yet observed — never does not exist.
NPS PHARMACEUTICALS INC
NPS PHARMACEUTICALS INC — US company (sec:0000890465). UBO chain traced 55 hops, 5 owners. Every claim linked to its source.
Ownership resolves 55 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- NPS PHARMACEUTICALS INC
None in current sources.
55-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on NPS PHARMACEUTICALS INC, resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
People & control
32 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- BESHAR LUKE MAlso holds roles at 5 other companies
- CAMBREX CORPofficer
- Protara Therapeutics, Inc.director
- Omega Therapeutics, Inc.director
- BIOTECHNOLOGY VALUE FUND II LPAlso holds roles at 100 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- AEOLUS PHARMACEUTICALS, INC.tenpercentowner
- BIOTECHNOLOGY VALUE FUND L PAlso holds roles at 106 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- AEOLUS PHARMACEUTICALS, INC.tenpercentowner
- BONNEY MICHAEL WAlso holds roles at 18 other companies
- CUBIST PHARMACEUTICALS INCofficer
- CUBIST PHARMACEUTICALS INCdirector
- IMMUNIC, INC.director
- BROOM COLIN MDAlso holds roles at 5 other companies
- VIROPHARMA INCofficer
- NABRIVA THERAPEUTICS AGdirector
- NABRIVA THERAPEUTICS AGofficer
- BROWN MORGAN RAlso holds roles at 4 other companies
- Clene Inc.officer
- Lipocine Inc.officer
- INNOVUS PHARMACEUTICALS, INC.officer
- BVF INC/ILAlso holds roles at 107 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- ADVANCED MAGNETICS INCtenpercentownerother
- BVF INVESTMENTS LLCAlso holds roles at 48 other companies
- AEOLUS PHARMACEUTICALS, INC.tenpercentowner
- ADVANCED MAGNETICS INCother
- CAPSTONE HOLDING CORP.other
- BVF PARTNERS L P/ILAlso holds roles at 110 other companies
- XOMA Royalty Corp10% owner
- Olema Pharmaceuticals, Inc.director
- ADVANCED MAGNETICS INCtenpercentownerother
- COSTA SANTO JAlso holds roles at 4 other companies
- Aquestive Therapeutics, Inc.director
- CYTOKINETICS INCdirector
- ONCOGENE SCIENCE INCdirector
- Cvijic Christine MikailAlso holds roles at 4 other companies
- Neurogene Inc.officer
- Neurogene Inc.director
- AXOVANT GENE THERAPIES LTD.officer
- FIRUTA PAUL EAlso holds roles at 2 other companies
- ACHILLION PHARMACEUTICALS INCofficer
- uniQure N.V.officer
- GARCEAU ROGERAlso holds roles at 2 other companies
- Protara Therapeutics, Inc.director
- Entera Bio Ltd.director
- GEMAYEL GEORGESAlso holds roles at 10 other companies
- SUPERNUS PHARMACEUTICALS, INC.director
- GENZYME CORPofficer
- Disc Medicine, Inc.director
- Graf Susan EAlso holds roles at 4 other companies
- Aardvark Therapeutics, Inc.director
- CG Oncology, Inc.director
- FINCH THERAPEUTICS GROUP, INC.director
- GRANADILLO PEDRO PAlso holds roles at 9 other companies
- FIRST INDIANA CORPdirector
- ROCKET PHARMACEUTICALS, INC.director
- Orchestra BioMed Holdings, Inc.director
- HARRIS ALAN GAlso holds roles at 3 other companies
- TG THERAPEUTICS, INC.officer
- MPM ACQUISITION CORPofficer
- LISATA THERAPEUTICS, INC.officer
- KLEIN JOSEPH IIIAlso holds roles at 7 other companies
- IONIS PHARMACEUTICALS INCdirector
- AKCEA THERAPEUTICS, INC.director
- BIO TECHNOLOGY GENERAL CORPdirector
- KUHLA DONALD EAlso holds roles at 3 other companies
- SYNTHETECH INCdirector
- ALBANY MOLECULAR RESEARCH INCdirector
- ALBANY MOLECULAR RESEARCH INCofficer
- Legault PierreAlso holds roles at 12 other companies
- Syndax Pharmaceuticals Incdirector
- BICYCLE THERAPEUTICS PLCdirector
- UROVANT SCIENCES LTD.director
- MICHEL GERARD JAlso holds roles at 6 other companies
- Beta Bionics, Inc.director
- DELCATH SYSTEMS, INC.officer
- DELCATH SYSTEMS, INC.director
- NADER FRANCOISAlso holds roles at 9 other companies
- Tectonic Therapeutic, Inc.director
- Moderna, Inc.director
- Tourmaline Bio, Inc.director
- O'CALLAGHAN BRIANAlso holds roles at 6 other companies
- BOLT BIOTHERAPEUTICS, INC.director
- OBSEVA SAdirector
- OBSEVA SAofficer
- Pauwels EricAlso holds roles at 3 other companies
- PTC THERAPEUTICS, INC.officer
- PTC THERAPEUTICS, INC.director
- ACCURAY INCofficer
- TOMBROS PETER GAlso holds roles at 5 other companies
- DENDRITE INTERNATIONAL INCdirector
- PROTALEX INCdirector
- CAMBREX CORPdirector
32 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns NPS PHARMACEUTICALS INC?
- What is NPS PHARMACEUTICALS INC's risk level?
- Where does NPS PHARMACEUTICALS INC appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for NPS PHARMACEUTICALS INC — nothing is disclosed before that.